The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway (PI3K/AKT) is frequently dysregulated in disorders of cell growth and survival, including a number of pediatric hematologic malignancies. Here, AKT1 is linked to hematologic disorder.